精密神经科学公司周四宣布，为其脑机接口技术完成了2.5亿美元的D轮融资，这家纽约公司表示。比尔·阿克曼的潘兴广场、阿克曼·奥克斯曼研究所和一家未具名的生命科学基金共同领投了此轮融资。
Precision Neuroscience has raised $250m in a Series D round for its brain-computer interface, the New York company announced on Thursday. Bill Ackman’s Pershing Square, the Ackman Oxman Institute and an unnamed life sciences fund led the round.
据《纽约时报》报道，此轮融资使精密神经科学公司的估值略高于10亿美元。据《纽约时报》报道，潘兴广场和该研究所共投入了4250万美元。精密神经科学公司成立于2021年，迄今已累计融资4.3亿美元。
The round values Precision at just over $1bn, The New York Times reported. Pershing Square and the institute put in $42.5m of the total, according to the Times. Precision, which started in 2021, has now raised $430m in total.
阿克曼的首笔投资：阿克曼与妻子内里·奥克斯曼在曼哈顿共同创立了阿克曼·奥克斯曼研究所，这是一个脑科学研究中 心。TNW曾在8月报道过他对该研究所的规划。据《纽约时报》报道，精密神经科学公司是该研究所的首笔投资。阿克曼告诉该报，精密神经科学公司侵入性较低的技术方案是吸引他的原因之一。
Ackman’s first bet Ackman founded the Ackman Oxman Institute, a brain research centre in Manhattan, with his wife, Neri Oxman. TNW covered his plans for the institute in August. Precision is the institute’s first investment, the Times reported. Ackman told the paper that Precision’s less invasive approach was part of what drew him in.
“我们已经了解到，大脑甚至可以从灾难性损伤中恢复，而且对于患有神经系统损伤的人来说，还有更多的事情可以做，”阿克曼在公司声明中表示。
“We have learned that the brain can recover from even catastrophic injury, and that there is far more that can be done for people living with neurological injuries,” Ackman said in the company’s statement.
此轮融资还吸引了杜肯家族办公室、B Capital、ARK Invest和Invus的参与。穆巴达拉资本、未来资产资本、韩国投资伙伴、日立创投和JSL健康资本也参与了投资。ARK同时也是Neuralink的投资者。
The round also drew the Duquesne Family Office, B Capital, ARK Invest and Invus. Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures and JSL Health Capital took part too. ARK is also an investor in Neuralink.
一层薄膜，而非探针：精密神经科学公司的Layer 7是一层带有1024个电极的薄膜，放置在大脑表面。Neuralink则将其电极植入脑组织内部。专家告诉《纽约时报》，表面设备感染或疤痕形成的风险较低。然而，大脑内部的电极可以读取单个神经元的活动，一些专家认为这可能使它们更加精确。
A thin film, not a probe Precision’s Layer 7 is a thin film with 1,024 electrodes that sits on the surface of the brain. Neuralink places its electrodes inside the brain tissue. Experts told the Times that surface devices carry less risk of infection or scarring. Electrodes inside the brain can read single neurons, however, which some experts think could make them more accurate.
据《纽约时报》报道，精密神经科学公司的创始人之一本杰明·拉波波特也是Neuralink的联合创始人。
One of Precision’s founders, Benjamin Rapoport, was also a co-founder of Neuralink, according to the Times.
美国食品药品监督管理局（FDA）于 2025 年 4 月批准了该设备的临时使用（使用期限为 30 天）。Precision 公司表示，该设备属于一款仍在开发中的无线植入式装置的一部分。首席执行官迈克尔·马格（Michael Mager）向《纽约时报》表示，这笔新获得的资金将用于推动该设备获得永久性植入许可的审批流程，这一过程可能需要数年时间。
The FDA cleared Layer 7 in April 2025 for up to 30 days of use. At the time, Precision said the device is one part of a wireless implant that is still in development. The new money will help it seek approval for permanent implants, chief executive Michael Mager told the Times. He said that is likely to take years.
马格在声明中表示：“脑机接口（BCI）技术的下一发展阶段将不仅仅取决于技术本身。”
“The next phase of BCI will be defined by more than technology alone,” Mager said in the statement.
据 Neurofounders 的报道，Precision 公司已在 18 家医疗机构为患者实施了超过 100 次相关手术。该公司还与美敦力（Medtronic）建立了合作关系，并在德克萨斯州自行生产电极阵列。Precision 正在为其完全可植入式的脑机接口系统开展初步可行性研究，旨在帮助严重瘫痪的患者恢复功能。
Precision says it has carried out more than 100 procedures on patients at 18 medical centres. It has also partnered with Medtronic and makes its own electrode arrays in Texas. Precision is preparing an early feasibility study of its fully implantable system, for people with severe paralysis, Neurofounders reported.
根据 Neurofounders 的数据，在过去 18 个月里，脑机接口技术领域已吸引了超过 20 亿美元的投资。Neuralink 的竞争对手 Paradromics 于 6 月将其首款脑芯片成功植入患者体内；中国也在 7 月将首款商用脑植入装置用于临床治疗。费恩斯坦研究所（Feinstein Institutes）的研究人员利用脑植入技术与人工智能技术，帮助一名瘫痪患者恢复了运动能力和触觉功能。
A crowded field More than $2bn has gone into brain-computer interface companies in the past 18 months, according to Neurofounders. Paradromics, a Neuralink rival, put its first brain chip into a patient in June. China put its first commercial brain implant into a patient in July. Researchers at the Feinstein Institutes have used an implant and AI to restore movement and touch to a paralysed man.